SEC Form 5 · accession 0001209191-15-013738
BIODELIVERY SCIENCES INTERNATIONAL INC · BDSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas D'Alonzo
Director
Period of report
Dec 31, 2014
Accepted (ET)
Feb 13, 2015 · 5:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001103021
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1 | $0.00 | Aug 12, 2014 | A | 20,000 | A | — | Aug 11, 2015 | Common Stock | 20,000 | 20,000 | D |
| Restricted Stock UnitsF1 | $0.00 | Aug 12, 2014 | J | 10,000 | D | — | Aug 11, 2015 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The restricted stock units ("RSUs") were issued to the Reporting Person on August 12, 2014, as compensation for service on the Issuer's board of directors. 10,000 RSUs vested immediately, and the acquisition of the common stock was reported on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on August 14, 2014. The remaining 10,000 RSUs vest on August 11, 2015. Upon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock.